000			01829 a2200541 4500
005			20250512080245.0
264		0	_c19860228
008			198602s 0 0 eng d
022			_a0163-4453
024	7		_a10.1016/s0163-4453(85)93063-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aDonnelly, J P
245	0	0	_aCeftazidime as first-line therapy for fever in acute leukaemia. _h[electronic resource]
260			_bThe Journal of infection _cNov 1985
300			_a205-15 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aBacterial Infections _xcomplications
650	0	4	_aCefotaxime _xtherapeutic use
650	0	4	_aCeftazidime _xadverse effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLeukemia _xcomplications
650	0	4	_aLeukemia, Lymphoid _xcomplications
650	0	4	_aLeukemia, Myeloid _xcomplications
650	0	4	_aLeukemia, Myeloid, Acute _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNetilmicin _xtherapeutic use
650	0	4	_aNeutropenia _xetiology
650	0	4	_aPenicillin Resistance
650	0	4	_aPiperacillin _xtherapeutic use
650	0	4	_aRandom Allocation
650	0	4	_aSepsis _xcomplications
700	1		_aMarcus, R E
700	1		_aGoldman, J M
700	1		_aCohen, J
700	1		_aWorsley, A M
700	1		_aCatovsky, D
700	1		_aDarrell, J H
700	1		_aWant, S V
700	1		_aGalton, D A
773	0		_tThe Journal of infection _gvol. 11 _gno. 3 _gp. 205-15
856	4	0	_uhttps://doi.org/10.1016/s0163-4453(85)93063-4 _zAvailable from publisher's website
999			_c3916418 _d3916418